SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): February 20, 2002 (February 7, 2002)
MAXXIM MEDICAL, INC.
| Texas | 0-18208 | 76-0291634 | ||
| (State or Other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||
950 Winter Street, Suite 2900, Waltham, Massachusetts 02451
Registrant’s telephone number, including area code (781) 906-0700
| Item 8. Change in Fiscal Year | ||||||||
| Signature | ||||||||
Item 8. Change in Fiscal Year
On February 7, 2002, Maxxim Medical, Inc. decided to change its fiscal year-end from a fiscal year ending on the Sunday nearest to October 31 to a fiscal year ending on the Sunday nearest to December 31. A report on Form 10-K, covering the transition period from October 29, 2001 to December 30, 2001, will be filed with the Securities and Exchange Commission in accordance with its rules and regulations.
Signature
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Maxxim Medical, Inc. | ||
| Date: February 20, 2002 | By: /s/ Mark S. Sellers | |
| Mark S. Sellers Vice Chairman and Chief Financial Officer | ||
